ALK-Abelló A/S (CPH:ALK.B)

Revenue by Segment

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Allergy Treatment	6.31B	5.54B	4.82B	4.51B	3.92B
Allergy Treatment Growth	14.00%	14.78%	6.94%	15.19%	12.17%
Total	6.31B	5.54B	4.82B	4.51B	3.92B
Total Growth	14.00%	14.78%	6.94%	15.19%	12.17%

Revenue by Geography

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Denmark	136.00M	141.00M	104.00M	119.00M	101.00M
Denmark Growth	-3.55%	35.58%	-12.61%	17.82%	21.69%
Germany	1.58B	1.38B	1.06B	902.20M	-
Germany Growth	14.00%	30.43%	17.63%	-	-
France	1.01B	941.29M	820.08M	811.98M	-
France Growth	7.29%	14.78%	1.00%	-	-
USA	883.68M	775.18M	771.84M	766.87M	-
USA Growth	14.00%	0.43%	0.65%	-	-
North America Excl. USA	153.32M	130.82M	136.16M	90.13M	-
North America Excl. USA Growth	17.20%	-3.92%	51.07%	-	-
Other Europe	1.74B	1.45B	1.23B	1.22B	-
Other Europe Growth	19.87%	17.62%	0.48%	-	-
International Markets	816.00M	717.00M	700.00M	190.01M	424.00M
International Markets Growth	13.81%	2.43%	268.40%	-55.19%	15.22%
Europe Excl. Denmark	-	-	-	-	2.71B
Europe Excl. Denmark Growth	-	-	-	-	9.77%
North America	-	-	-	-	683.00M
North America Growth	-	-	-	-	19.20%
Japan	-	-	-	405.99M	-
Total	6.31B	5.54B	4.82B	4.51B	3.92B
Total Growth	14.00%	14.78%	6.94%	15.19%	12.17%

Source: S&P Global Market Intelligence.